enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. CRISPR Therapeutics - Wikipedia

   en.wikipedia.org/wiki/CRISPR_Therapeutics

   CRISPR Therapeutics AG is a Swiss–American biotechnology company headquartered in Zug, Switzerland.It was one of the first companies formed to utilize the CRISPR gene editing platform to develop medicines for the treatment of various rare and common diseases.

3. CRISPR Therapeutics Provides Business Update and Reports ...

   lite.aol.com/tech/story/0022/20241105/9267676.htm

   CRISPR Therapeutics has two next generation approaches with the potential to significantly expand the addressable population with SCD and TDT. The Company continues to advance its internally developed targeted conditioning program, an anti-CD117 (c-Kit) antibody-drug conjugate (ADC), through preclinical studies.

4. This Beaten-Down Biotech Stock Just Got Some Good News: Time ...

   www.aol.com/finance/beaten-down-biotech-stock...

   Since November 2023, CRISPR Therapeutics has been earning approvals for Casgevy, a gene-editing medicine, in various countries and regions. This new coverage could also make it easier once CRISPR ...

5. Could CRISPR Therapeutics Become the Next Vertex ... - AOL

   www.aol.com/could-crispr-therapeutics-become...

   CRISPR Therapeutics, in its latest earnings report, said more than 25 Casgevy authorized treatment centers are up and running, and multiple patients have begun the treatment process.

6. 3 Things You Need to Know if You Buy CRISPR Therapeutics Today

   www.aol.com/3-things-know-buy-crispr-144500442.html

   CRSP Market Cap data by YCharts. 3. Intensive competition. The success of CRISPR Therapeutics will depend on its ability to bring multiple new drugs to the market to support a more viable business ...

7. CRISPR Therapeutics Presents Data at the 2024 American ...

   lite.aol.com/tech/story/0022/20241209/9316263.htm

   ZUG, Switzerland and BOSTON, Dec. 09, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today presented data from the Company’s ongoing Phase 1/2 dose escalation clinical trial evaluating the safety and efficacy of CTX112™, a ...

8. CRISPR Therapeutics Proposes New Appointment to the Board of ...

   lite.aol.com/tech/story/0022/20250107/9327277.htm

   About CRISPR Therapeutics Since its inception over a decade ago, CRISPR Therapeutics has transformed from a research-stage company advancing programs in the field of gene editing, to a company that celebrated the historic approval of the first-ever CRISPR-based therapy in 2023 and has a diverse portfolio of product candidates across a broad ...

9. FDA Approves First CRISPR Treatment in U.S. - AOL

   www.aol.com/fda-approves-first-crispr-treatment...

   The U.K. had already approved the CRISPR treatment, called exa-cel (brand name: Casgevy), from Vertex Pharmaceuticals and CRISPR Therapeutics (which was co-founded by Charpentier), to treat people ...